The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Cystic Fibrosis
Abstract
This article reviews the pathophysiology, evaluation, and treatment of cystic fibrosis, including recent advances with the use of highly effective modulator therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908639 · Cited by 2,198
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Self-citationLumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409547 · Cited by 1,622
Self-citationThe future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Self-citationDiagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., Howenstine, M., McColley, S. A., Rock, M., Rosenfeld, M., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.064 · Cited by 953
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., Belousova, E. G., Xuan, W., & Bye, P. T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043900 · Cited by 862
Corey, M., McLaughlin, F. J., Williams, M., & Levison, H. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90063-7 · Cited by 815
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
Pezzulo, A. A., Tang, X. X., Hoegger, M. J., Abou Alaiwa, M. H., Ramachandran, S., Moninger, T. O., Karp, P. H., Wohlford-Lenane, C. L., Haagsman, H. P., van Eijk, M., et al. (2012) · Nature · doi:10.1038/nature11130 · Cited by 808
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 807
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Taylor-Cousar, J. L., Munck, A., McKone, E. F., van der Ent, C. K., Moeller, A., Simard, C., Wang, L. T., Ingenito, E. P., McKee, C., Lu, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709846 · Cited by 794
Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1845pp · Cited by 738
VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Keating, D., Marigowda, G., Burr, L., Daines, C., Mall, M. A., McKone, E. F., Ramsey, B. W., Rowe, S. M., Sass, L. A., Tullis, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1807120 · Cited by 726
Origins of Cystic Fibrosis Lung Disease
Stoltz, D. A., Meyerholz, D. K., & Welsh, M. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300109 · Cited by 669
Ratjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Self-citationTezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Rowe, S. M., Daines, C., Ringshausen, F. C., Kerem, E., Wilson, J., Tullis, E., Nair, N., Simard, C., Han, L., Ingenito, E. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709847 · Cited by 522
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207488 · Cited by 465
Role of CFTR in epithelial physiology
Saint-Criq, V., & Gray, M. A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2391-y · Cited by 433
Recommendations for the classification of diseases as CFTR-related disorders
Bombieri, C., Claustres, M., De Boeck, K., Derichs, N., Dodge, J., Girodon, E., Sermet, I., Schwarz, M., Tzetis, M., Wilschanski, M., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60014-3 · Cited by 429
Amin, R., Dupuis, A., Aaron, S. D., & Ratjen, F. (2010) · Chest · doi:10.1378/chest.09-1103 · Cited by 376
Self-citationTriple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes
Barry, P. J., Mall, M. A., Álvarez, A., Colombo, C., de Winter-de Groot, K. M., Fajac, I., McBennett, K. A., McKone, E. F., Ramsey, B. W., Sutharsan, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100665 · Cited by 283
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Brady, C., Guill, M., Lahiri, T., Lubsch, L., Matsui, J., Oermann, C. M., Ratjen, F., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-166oc · Cited by 269
Self-citationVolkova, N., Moy, K., Evans, J., Campbell, D., Tian, S., Simard, C., Higgins, M., Konstan, M. W., Sawicki, G. S., Elbert, A., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.05.015 · Cited by 258
Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis
Ooi, C. Y., Dorfman, R., Cipolli, M., Gonska, T., Castellani, C., Keenan, K., Freedman, S. D., Zielenski, J., Berthiaume, Y., Corey, M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.046 · Cited by 254
Nichols, D. P., Morgan, S. J., Skalland, M., Vo, A. T., Van Dalfsen, J. M., Singh, S. B. P., Ni, W., Hoffman, L. R., McGeer, K., Heltshe, S. L., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167957 · Cited by 222
Sabatino, D. E., Bushman, F. D., Chandler, R. J., Crystal, R. G., Davidson, B. L., Dolmetsch, R., Eggan, K. C., Gao, G., Gil-Farina, I., Kay, M. A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.004 · Cited by 212
Stephenson, A. L., Sykes, J., Stanojevic, S., Quon, B. S., Marshall, B. C., Petren, K., Ostrenga, J., Fink, A. K., Elbert, A., & Goss, C. H. (2017) · Annals of Internal Medicine · doi:10.7326/m16-0858 · Cited by 192
Zhou-Suckow, Z., Duerr, J., Hagner, M., Agrawal, R., & Mall, M. A. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2562-z · Cited by 189
Sun, X., Yi, Y., Yan, Z., Rosen, B. H., Liang, B., Winter, M. C., Evans, T. I. A., Rotti, P. G., Yang, Y., Gray, J. S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau7531 · Cited by 188
Sutharsan, S., McKone, E. F., Downey, D. G., Duckers, J., MacGregor, G., Tullis, E., Braeckel, E. V., Wainwright, C. E., Watson, D., Ahluwalia, N., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00454-9 · Cited by 178
Munck, A., Mayell, S. J., Winters, V., Shawcross, A., Derichs, N., Parad, R., Barben, J., & Southern, K. W. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.01.001 · Cited by 176
McGarry, M. E., & McColley, S. A. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25285 · Cited by 171
Mall, M. A., Brugha, R. E., Gärtner, S., Legg, J. P., Mœller, A., Mondéjar-López, P., Prais, D., Pressler, T., Ratjen, F. A., Reix, P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0392oc · Cited by 170
Self-citationMayer-Hamblett, N., Ratjen, F. A., Russell, R., Donaldson, S. H., Riekert, K. A., Sawicki, G. S., Odem‐Davis, K., Young, J., Rosenbluth, D., Taylor‐Cousar, J. L., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00434-9 · Cited by 160
Self-citationRowe, S. M., Zuckerman, J. B., Dorgan, D., Lascano, J., McCoy, K., Jain, M., Schechter, M. S., Lommatzsch, S., Indihar, V., Lechtzin, N., et al. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.04.008 · Cited by 160
Pulmonary Complications of Cystic Fibrosis
Flume, P. A. (2009) · Respiratory Care · doi:10.4187/aarc0443 · Cited by 154
Goralski, J. L., Hoppe, J. E., Mall, M. A., McColley, S. A., McKone, E. F., Ramsey, B. W., Rayment, J. H., Robinson, P. J., Stehling, F., Taylor‐Cousar, J. L., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0084oc · Cited by 152
Self-citationReal-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
Dagenais, R., Su, V., & Quon, B. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010023 · Cited by 144
Graeber, S. Y., Renz, D. M., Stahl, M., Pallenberg, S. T., Sommerburg, O., Naehrlich, L., Berges, J., Dohna, M., Ringshausen, F. C., Doellinger, F., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0219oc · Cited by 129
Alvarez, J. A., Ziegler, T. R., Millson, E. C., & Stecenko, A. A. (2015) · Nutrition · doi:10.1016/j.nut.2015.10.012 · Cited by 121
Dornase alfa for cystic fibrosis
Yang, C. L., & Montgomery, M. D. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001127.pub5 · Cited by 116
Ratjen, F. A., Davis, S. D., Stanojevic, S., Kronmal, R. A., Stukovsky, K. H., Jorgensen, N. W., Rosenfeld, M., Kerby, G. S., Kopecky, C. M., Anthony, M., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30187-0 · Cited by 115
Self-citationSzentpetery, S., Foil, K. E., Hendrix, S. J., Gray, S., Mingora, C. M., Head, B., Johnson, D., & Flume, P. A. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.04.005 · Cited by 109
Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection
Blanchard, A. C., & Waters, V. J. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac052 · Cited by 104
Early lung disease in cystic fibrosis
Grasemann, H., & Ratjen, F. A. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70026-2 · Cited by 101
Self-citationInhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis
Smith, S., Rowbotham, N. J., & Regan, K. H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001021.pub3 · Cited by 92
Donaldson, S. H., Laube, B. L., Corcoran, T. E., Bhambhvani, P. G., Zeman, K. L., Ceppe, A., Zeitlin, P. L., Mogayzel, P. J., Boyle, M., Locke, L. W., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122695 · Cited by 79
Cystic fibrosis bone disease treatment: Current knowledge and future directions
Putman, M. S., Anabtawi, A., Le, T. N. H., Tangpricha, V., & Sermet‐Gaudelus, I. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.017 · Cited by 78
The Changing Epidemiology of Cystic Fibrosis
Burgel, P., Burnet, E., Regard, L., & Martin, C. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.07.004 · Cited by 78
Nagy, R., Gede, N., Ocskay, K., Dobai, B. M., Abada, A., Vereczkei, Z., Pázmány, P., Kató, D., Hegyi, P. J., & Párniczky, A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0740 · Cited by 74
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010004.pub5 · Cited by 71
Self-citationMartin, C., Reynaud‐Gaubert, M., Hamidfar, R., Durieu, I., Murris‐Espin, M., Danner‐Boucher, I., Chiron, R., Leroy, S., Douvry, B., Grenet, D., et al. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.01.012 · Cited by 67
Montgomery, S., Dittrich, S. A., Garratt, L. W., Turkovic, L., Frey, D. L., Stick, S. M., Mall, M. A., & Kicic, A. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.05.006 · Cited by 66
Lung transplantation for cystic fibrosis
Yeung, J. C., Machuca, T., Chaparro, C., Cypel, M., Stephenson, A. L., Solomon, M. P., Saito, T., Binnie, M., Chow, C., Grasemann, H., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.02.010 · Cited by 63
Self-citationOren, Y. S., Sinai, M. I., Golec, A., Barchad-Avitzur, O., Mutyam, V., Yao, L., Hong, J. S., Ozeri-Galai, E., Hatton, A., Leibson, C., et al. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.06.003 · Cited by 61
Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
Zhang, L., Albon, D. P., Jones, M., & Bruschwein, H. M. (2022) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666221144211 · Cited by 59
Streibel, C., Willers, C., Pusterla, O., Bauman, G., Stranzinger, E., Brabandt, B., Bieri, O., Curdy, M., Bullo, M., Frauchiger, B., et al. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.12.012 · Cited by 59
Self-citationCurrent state of CFTR modulators for treatment of Cystic Fibrosis
Despotes, K. A., & Donaldson, S. H. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102239 · Cited by 58
Piehler, L., Thalemann, R., Lehmann, C., Thee, S. A., Roehmel, J. F., Syunyaeva, Z., Stahl, M., Mall, M. A., & Graeber, S. Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1179208 · Cited by 56
Li, X., Tang, X. X., Buonfiglio, L. G. V., Comellas, A. P., Thornell, I. M., Ramachandran, S. S., Karp, P. H., Taft, P. J., Sheets, K. A., Alaiwa, M. H. A., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00422.2015 · Cited by 53
Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
Ramalho, A. S., Boon, M., Proesmans, M., Vermeulen, F. L., Carlon, M. S., & Boeck, K. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031437 · Cited by 52
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis
Smith, S. J., & Rowbotham, N. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001021.pub4 · Cited by 52
Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
Ramos, K. J., Guimbellot, J. S., Valapour, M., Bartlett, L., Wai, T. H., Goss, C. H., Pilewski, J. M., Faro, A., & Diamond, J. M. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.04.009 · Cited by 49
Tewkesbury, D. H., Athwal, V. S., Bright-Thomas, R. J., Jones, A. M., & Barry, P. J. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.01.007 · Cited by 49
CFTR Modulator Therapy for Cystic Fibrosis
Grasemann, H. (2017) · New England Journal of Medicine · doi:10.1056/nejme1712335 · Cited by 48
Self-citationTreatment Preference Among People With Cystic Fibrosis
Cameron, R. A., Daniel Office, Matthews, J., Rowley, M., Abbott, J., Simmonds, N. J., Whitty, J. A., & Carr, S. B. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.07.008 · Cited by 47
Steinack, C., Ernst, M., Beuschlein, F., Hage, R., Roeder, M., Schuurmans, M. M., Schmid, C., & Gaisl, T. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.01.004 · Cited by 45
Tiddens, H. A. W. M., Chen, Y., Andrinopoulou, E., Davis, S. D., Rosenfeld, M., Ratjen, F. A., Kronmal, R. A., Stukovsky, K. H., Dasiewicz, A. S. B., Stick, S. M., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00546-4 · Cited by 44
Self-citationGuta, M. T., Tekalign, T., Awoke, N., Fite, R. O., Dendir, G., & Lenjebo, T. L. (2021) · International Journal of Chronic Diseases · doi:10.1155/2021/6708865 · Cited by 40
Contemporary cystic fibrosis incidence rates in Canada and the United States
Stephenson, A. L., Swaleh, S., Sykes, J. R., Stanojevic, S., Ma, X., Quon, B. S., Faro, A., Marshall, B. C., Ramos, K. J., Ostrenga, J., et al. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.10.008 · Cited by 40
Variation in cystic fibrosis newborn screening algorithms in the United States
Rehani, M. R., Marcus, M. S. K., Harris, A. B., Farrell, P. M., & Ren, C. L. (2022) · Pediatric Pulmonology · doi:10.1002/ppul.26279 · Cited by 40
Ratjen, F. A., Klingel, M. L., Black, P., Powers, M. R., Grasemann, H., Solomon, M. P., Sagel, S. D., Donaldson, S. H., Rowe, S. M., & Rosenfeld, M. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201802-0243le · Cited by 39
Self-citationCystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment
Alves, C., DellaManna, T., & Albuquerque, C. T. M. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0484 · Cited by 38
Currier, R. J., Sciortino, S., Liu, R., Bishop, T., Alikhani Koupaei, R., & Feuchtbaum, L. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.32 · Cited by 35
One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies
Ensinck, M. M., & Carlon, M. S. (2022) · Cells · doi:10.3390/cells11121868 · Cited by 34
Progress in Respiratory Gene Therapy
McLachlan, G., Alton, E. W. F. W., Boyd, A., Clarke, N. K., Davies, J. C., Gill, D. R., Griesenbach, U., Hickmott, J. W., Hyde, S. C., Miah, K. M., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.172 · Cited by 33
Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
Coriati, A., Ma, X., Sykes, J. R., Stanojevic, S., Ruseckaite, R., Lemonnier, L., Dehillotte, C., Tate, J., Byrnes, C. A., Bell, S. C., et al. (2022) · Thorax · doi:10.1136/thorax-2022-219086 · Cited by 32
Aquagenic Wrinkling of the Palms in a Patient with Cystic Fibrosis
Grasemann, H., Ratjen, F. A., & Solomon, M. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1308349 · Cited by 27
Self-citationHarwood, K. H., McQuade, R. M., Jarnicki, A., & Schneider‐Futschik, E. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147606 · Cited by 27
Ramos, K. J., Sykes, J. R., Stanojevic, S., Ma, X., Ostrenga, J. S., Fink, A. K., Quon, B. S., Marshall, B. C., Faro, A., Petren, K., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.04.010 · Cited by 25
Manti, S., Giallongo, A., Parisi, G. F., Papale, M. R., Mulè, E., Aloisio, D., Rotolo, N., & Leonardi, S. (2022) · European Respiratory Review · doi:10.1183/16000617.0011-2022 · Cited by 25
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010004.pub2 · Cited by 20
Self-citationTaylor‐Cousar, J. L., Shteinberg, M., Cohen‐Cymberknoh, M., & Jain, R. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.01.016 · Cited by 19
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care
Mulrennan, S. A., Sapru, K., Tewkesbury, D. H., & Jones, A. M. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758734 · Cited by 12
McBennett, K., MacAskill, C. J., Keshock, E., Mahani, M. G., Mata, J. F., Towbin, A. J., Sankararaman, S., Drumm, M. L., Yu, X., Ren, C. L., et al. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.11.006 · Cited by 11
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
Vélez, C. D., Freedman, S. D., & Assis, D. N. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.07.001 · Cited by 5
Sahakyan, Y., Abrahamyan, L., Ratjen, F. A., Bear, C. E., Strug, L. J., Eckford, P. D. W., Peel, J. K., Krahn, M. D., & Sander, B. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.04.013 · Cited by 5
Self-citation
Cited by
Singh, T. P., Hsich, E., Cherikh, W. S., Perch, M., Hayes, D., Lewis, A., Dellgren, G., & Cogswell, R. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.04.014 · Cited by 135
Metadata
- Authors
- Grasemann, H., & Ratjen, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-11-02
- Volume
- 389
- Issue
- 18
- Pages
- 1693-1707
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4388120536
- Cited by
- 334
- References
- 86
- FWCI
- 53.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.